HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Aug. 11, 2022 (HealthDay News) -- COVID-19 infection in pregnant women is associated with worse outcomes than in women who are not pregnant, according to a state-of-the-art review published online Aug. 10 in JACC: Advances.
Joan E. Briller, M.D., from the University of Illinois at Chicago, and colleagues address pregnancy-associated COVID-19 cardiovascular complications.
The researchers note that pregnant women with COVID-19 infection are more likely to have severe outcomes, including intensive care unit admission, mechanical ventilation, and death. Mechanisms for adverse outcomes in pregnant individuals may reflect more serious outcomes of viral infection in pregnancy, immune system changes, increased clotting risk, older age, and underlying comorbidities. COVID-19-associated cardiac complications, including myocardial injury, arrhythmias, and heart failure, may require change to management during pregnancy. Furthermore, unique pregnancy complications, including preeclampsia, peripartum cardiomyopathy, and spontaneous coronary dissections, need to be differentiated from COVID-19-associated complications. For patients with cardiac disease after COVID-19 infection, a multidisciplinary cardio-obstetrics team should be involved in preconception planning and pregnancy management.
"Recognition of cardiovascular complication is hampered by failure to include pregnant women in clinical trials despite calls for inclusion of pregnant populations," Briller said in a statement. "Consequently, women may be undertreated or inadequately treated due to lack [of] studies addressing safety and efficacy of therapies during pregnancy or conversely be exposed to therapies where safety is not known."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022